查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1459597

全球内分泌检测市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Endocrine Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 215 Pages | 商品交期: 最快1-2个工作天内

价格

全球内分泌检测市场需求预计将从 2023 年的 126.1 亿美元增至 2032 年近 285.4 亿美元，2024-2032 年研究期间复合CAGR为 9.5%。

内分泌测试涉及评估内分泌系统的诊断程序，内分泌系统调节体内的荷尔蒙。这些测试测量血液、尿液或唾液样本中的荷尔蒙水平，以检测与糖尿病、甲状腺疾病和生殖健康问题相关的异常或不平衡。它们有助于诊断和监测内分泌失调并指导适当的治疗。

市场动态

糖尿病、甲状腺疾病和荷尔蒙失衡等内分泌疾病的盛行率不断上升，推动了对评估内分泌功能的诊断测试的需求。随着全球慢性病盛行率持续上升，对内分泌疾病准确、及时诊断的需求日益增长。内分泌检测是此过程中的重要工具，有助于早期发现和干预，指导治疗决策并改善患者的治疗结果。此外，免疫分析、色谱和分子诊断等诊断技术的进步正在扩大内分泌检测方法的能力和准确性，进一步推动市场成长。此外，人口老化的加剧以及以久坐行为和不健康饮食习惯为特征的生活方式的改变导致内分泌疾病的增加，从而增加了对内分泌检测服务的需求。此外，将内分泌检测纳入常规健康检查和健康计划可促进内分泌失调的早期发现和干预，从而推动市场扩张。此外，政府为提高人们对内分泌健康的认识和改善医疗保健服务的可及性而采取的支持性倡议，透过促进内分泌疾病的常规检测和筛检，推动了市场的成长。然而，与先进测试方法、报销限制和监管障碍相关的高成本可能会在一定程度上阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球内分泌检测市场的每个细分市场进行包容性评估。内分泌检测产业的成长和趋势为本研究提供了整体方法。

市场区隔

内分泌检测市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按测试类型

  • 雌二醇（E2）测试
  • 卵泡刺激素 (Fsh) 测试
  • 人类绒毛膜促性腺激素 (Hcg) 荷尔蒙测试
  • 黄体生成素 (Lh) 测试
  • 硫酸脱氢表雄酮（Dheas）测试
  • 黄体酮测试
  • 睪酮测试
  • 促甲状腺激素 (Tsh) 测试
  • 催乳素测试
  • 皮质醇测试
  • 胰岛素测试
  • 其他的

依技术

  • 串联质谱法
  • 免疫分析
  • 单株和多株抗体抗体技术
  • 感测器技术
  • 临床化学
  • 其他的

按最终用途

  • 医院
  • 商业实验室
  • 门诊护理中心
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲内分泌检测市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。内分泌检测市场的主要参与者包括 Abbott Laboratories、AB Sciex、Agilent Technologies Inc.、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Laboratory Corporation of America Holdings、Quest Diagnostics公司，Ortho 临床诊断。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：内分泌检测 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按测试类型进行的市场吸引力分析
    • 按技术分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球内分泌检测市场分析：依测试类型

  • 按测试类型概述
  • 历史和预测数据
  • 按测试类型分析
  • 雌二醇（E2）测试
  • 卵泡刺激素 (FSH) 测试
  • 人类绒毛膜促性腺激素 (hCG) 荷尔蒙测试
  • 黄体生成素 (LH) 测试
  • 硫酸去氢表雄酮 (DHEAS) 测试
  • 黄体酮测试
  • 睪酮测试
  • 促甲状腺激素 (TSH) 测试
  • 催乳素测试
  • 皮质醇测试
  • 胰岛素测试
  • 其他的

第 6 章：全球内分泌检测市场分析：依技术分类

  • 依技术概述
  • 历史和预测数据
  • 依技术分析
  • 串联质谱法
  • 免疫分析
  • 单株和多株抗体抗体技术
  • 感测器技术
  • 临床化学
  • 其他的

第 7 章：全球内分泌检测市场分析：依最终用途分类

  • 按最终用途分類的概述
  • 历史和预测数据
  • 按最终用途分析
  • 医院
  • 商业实验室
  • 门诊护理中心
  • 其他的

第 8 章：全球内分泌检测市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：内分泌检测公司的竞争格局

  • 内分泌检测市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Abbott Laboratories
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AB Sciex
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Agilent Technologies Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • bioMerieux SA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bio-Rad Laboratories Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • DiaSorin SpA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • F. Hoffmann-La Roche Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Laboratory Corporation of America Holdings
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Quest Diagnostics Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Ortho Clinical Diagnostics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112114091

The global demand for Endocrine Testing Market is presumed to reach the market size of nearly USD 28.54 Billion by 2032 from USD 12.61 Billion in 2023 with a CAGR of 9.5% under the study period 2024 - 2032.

Endocrine testing involves diagnostic procedures to assess the endocrine system, which regulates hormones within the body. These tests measure hormone levels in blood, urine, or saliva samples to detect abnormalities or imbalances related to diabetes, thyroid disorders, and reproductive health issues. They aid in diagnosing and monitoring endocrine disorders and guiding appropriate treatment.

MARKET DYNAMICS

The growing prevalence of endocrine disorders, like diabetes, thyroid disorders, and hormonal imbalances, is driving the demand for diagnostic tests to assess endocrine function. With the ongoing global prevalence of chronic diseases continuing to rise, there is a growing need for accurate and timely diagnosis of endocrine disorders. Endocrine testing, a crucial tool in this process, aids in early detection and intervention, guiding treatment decisions and improving patient outcomes. Moreover, advancements in diagnostic technologies, such as immunoassays, chromatography, and molecular diagnostics, are expanding the capabilities and accuracy of endocrine testing methods, further driving market growth. Additionally, the growing aging population and changing lifestyles characterized by sedentary behavior and unhealthy dietary habits contribute to the rise in endocrine disorders, increasing the demand for endocrine testing services. Furthermore, integrating endocrine testing into routine health screenings and wellness programs drives market expansion by facilitating early detection and intervention for endocrine disorders. Moreover, supportive government initiatives to raise awareness about endocrine health and improve access to healthcare services are fueling market growth by promoting routine testing and screening for endocrine disorders. However, high costs associated with advanced testing methods, reimbursement constraints, and regulatory hurdles will likely hinder market growth to some extent.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of endocrine testing. The growth and trends of endocrine testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the endocrine testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (Fsh) Test
  • Human Chorionic Gonadotropin (Hcg) Hormone Test
  • Luteinizing Hormone (Lh) Test
  • Dehydroepiandrosterone Sulfate (Dheas) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (Tsh) Test
  • Prolactin Test
  • Cortisol Test
  • Insulin Test
  • Others

By Technology

  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal & Polyclonal Antibody Technologies
  • Sensor Technology
  • Clinical Chemistry
  • Others

By End-Use

  • Hospitals
  • Commercial Laboratories
  • Ambulatory Care Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Endocrine Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Endocrine Testing market include Abbott Laboratories, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Ortho Clinical Diagnostics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ENDOCRINE TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Test Type
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ENDOCRINE TESTING MARKET ANALYSIS BY TEST TYPE

  • 5.1 Overview by Test Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Test Type
  • 5.4 Estradiol (E2) Test Historic and Forecast Sales by Regions
  • 5.5 Follicle Stimulating Hormone (FSH) Test Historic and Forecast Sales by Regions
  • 5.6 Human Chorionic Gonadotropin (hCG) Hormone Test Historic and Forecast Sales by Regions
  • 5.7 Luteinizing Hormone (LH) Test Historic and Forecast Sales by Regions
  • 5.8 Dehydroepiandrosterone Sulfate (DHEAS) Test Historic and Forecast Sales by Regions
  • 5.9 Progesterone Test Historic and Forecast Sales by Regions
  • 5.10. Testosterone Test Historic and Forecast Sales by Regions
  • 5.11 Thyroid Stimulating Hormone (TSH) Test Historic and Forecast Sales by Regions
  • 5.12 Prolactin Test Historic and Forecast Sales by Regions
  • 5.13 Cortisol Test Historic and Forecast Sales by Regions
  • 5.14 Insulin Test Historic and Forecast Sales by Regions
  • 5.15 Others Historic and Forecast Sales by Regions

6 . GLOBAL ENDOCRINE TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 6.1 Overview by Technology
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Technology
  • 6.4 Tandem Mass Spectrometry Historic and Forecast Sales by Regions
  • 6.5 Immunoassay Historic and Forecast Sales by Regions
  • 6.6 Monoclonal & Polyclonal Antibody Technologies Historic and Forecast Sales by Regions
  • 6.7 Sensor Technology Historic and Forecast Sales by Regions
  • 6.8 Clinical Chemistry Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL ENDOCRINE TESTING MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-use
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Commercial Laboratories Historic and Forecast Sales by Regions
  • 7.6 Ambulatory Care Centers Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL ENDOCRINE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ENDOCRINE TESTING COMPANIES

  • 9.1. Endocrine Testing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ENDOCRINE TESTING INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott Laboratories
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. AB Sciex
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Agilent Technologies Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. bioMerieux SA
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Bio-Rad Laboratories Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. DiaSorin S.p.A.
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Laboratory Corporation of America Holdings
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Quest Diagnostics Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Ortho Clinical Diagnostics
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Test Type (USD MN)
  • Estradiol (E2) Test Market Sales by Geography (USD MN)
  • Follicle Stimulating Hormone (FSH) Test Market Sales by Geography (USD MN)
  • Human Chorionic Gonadotropin (hCG) Hormone Test Market Sales by Geography (USD MN)
  • Luteinizing Hormone (LH) Test Market Sales by Geography (USD MN)
  • Dehydroepiandrosterone Sulfate (DHEAS) Test Market Sales by Geography (USD MN)
  • Progesterone Test Market Sales by Geography (USD MN)
  • Testosterone Test Market Sales by Geography (USD MN)
  • Thyroid Stimulating Hormone (TSH) Test Market Sales by Geography (USD MN)
  • Prolactin Test Market Sales by Geography (USD MN)
  • Cortisol Test Market Sales by Geography (USD MN)
  • Insulin Test Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Tandem Mass Spectrometry Market Sales by Geography (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Monoclonal & Polyclonal Antibody Technologies Market Sales by Geography (USD MN)
  • Sensor Technology Market Sales by Geography (USD MN)
  • Clinical Chemistry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Commercial Laboratories Market Sales by Geography (USD MN)
  • Ambulatory Care Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Endocrine Testing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Endocrine Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Endocrine Testing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Test Type
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Test Type (USD MN)
  • Estradiol (E2) Test Market Sales by Geography (USD MN)
  • Follicle Stimulating Hormone (FSH) Test Market Sales by Geography (USD MN)
  • Human Chorionic Gonadotropin (hCG) Hormone Test Market Sales by Geography (USD MN)
  • Luteinizing Hormone (LH) Test Market Sales by Geography (USD MN)
  • Dehydroepiandrosterone Sulfate (DHEAS) Test Market Sales by Geography (USD MN)
  • Progesterone Test Market Sales by Geography (USD MN)
  • Testosterone Test Market Sales by Geography (USD MN)
  • Thyroid Stimulating Hormone (TSH) Test Market Sales by Geography (USD MN)
  • Prolactin Test Market Sales by Geography (USD MN)
  • Cortisol Test Market Sales by Geography (USD MN)
  • Insulin Test Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Tandem Mass Spectrometry Market Sales by Geography (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Monoclonal & Polyclonal Antibody Technologies Market Sales by Geography (USD MN)
  • Sensor Technology Market Sales by Geography (USD MN)
  • Clinical Chemistry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Commercial Laboratories Market Sales by Geography (USD MN)
  • Ambulatory Care Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.